CRT 2024

CARDIOGENIC SHOCK: PAST, PRESENT, AND FUTURE CLINICAL TRIALS

Moderator(s)

• 

  Srihari S. Naidu, MD, FSCAI

  Director, Cath Labs and HCM Program
  Westchester Medical Center
  Valhalla, New York, United States

  No relationships to disclose
• 

  Michele D. Voeltz, MD, FACC, FSCAI

  Attending Physician
  Northside Cardiovascular Institute
  Buford, Georgia, United States

  Disclosure(s): Medtronic, Pulnovo, Abiomed, Amgen, Boehringer Ingelheim: Advisor (Ongoing)